Uncertainties surrounding the U.S. pharmaceutical sector and the turbulent development in global stock markets have led to ...

Ltd, the AAR concluded that these services fall under the Service Accounting Code (SAC) 998111, classified as ‘Research and ...

A new podcast led by alumni offers students interested in healthcare a behind-the-scenes look at the many careers within the industry, highlighting the stories, struggles, and successes of those ...

Republican primary for Ohio governor, Attorney General Dave Yost finds himself facing an uphill climb against Vivek ...

The pipeline purge comes less than a year after Caribou cut 12% of staff and ended its natural killer (NK) cell therapy ...

The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

NovoCure (NASDAQ: NVCR) published its first set of quarterly results for 2025, and they pleased more than a few investors.

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Montreal, Quebec-based Canadian biotech firm EVAH Corporation has secured a U.S. patent for Barracuda, its new in-feed sea ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its high-content imaging technology and AI-powered analysis used to speed drug discovery ...